PTO/SB/96 (97-09)
`Approved for use through 07/31/2012. OMB 6651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Pagerwcth Redehsan AchatTSS, no peroneare racuirendto TEsand to a collection of iforviation Unleos: ittania yo @ seaiticl OMe. gentlest auiiver:
`
`STATEMENT UNDER 37 CFR 3.73(6}
`
`tiomeyDocketNumber: 105153-
`Robert A. ASHLEY
`Applicant/Patent Owner:
`13/277,789
`“Filed/issueDate:
`10/20/2014
`~
`_
`| Application No./Patent No.:
`
`“METHODS OF TREATINGACNE
`Titled:
`_GaldermaLaboratories, Inc.eect
`{Rame of Assignee)
`ee
`
`Corporation
`‘Type of Assionee, o.g., corporation, partnership, university,
`government agenay, ete.)
`
`.
`
`j States that it is:
`
`&
`2.
`
`the assignee of the entire right, fille, and interest;
`an assignee of less than the entire right, title, and interest
`(The extent (oy percentage) of its ownership interest is %), or
`& ihe assignee of an undivided interest in the entirety of (a cornplete assignment from one of the joint inventors was made)
`
`in the patent application/patentidentified above by virtue of either:
`
`A.C] An assignment from the inventar(s) of the patent application/patentidentified above. The assignment was recordedin the
`United States Patent and Trademark Office al Reel
`Frame
`, of for which a copy thereof is attached.
`
`OR
`
`B. EK A chain oftitle from the Inventor(s), of the patent anplication/patent identified above, to the current assignee as follows:
`To: _ COLLAGENER|PHARMACEUTICALS.IMG.
`
`Thedocument was recordedin the United States Patent and Trademark Office at
`
`
`, or for which a copy thereofis attached.
`
`:__.. Frame 0499
`
`To: _GALDERMA LABORTORIES ING.
`ROLLAGENEXPHARMAGEUTICAUS.ING...
`2. From:
`
`The document was recorded in the United States Patent and Trademark Office at
`ReelOSkeo8
`. Frame
`0872
`_ or for which a copy thereofis attached.
`
`;
`
`cialBinbadUDBeReaSE
`
`
`SEL ITALENC: To: GALDERMALABORATORIESING._.
`3. From: CCHLLASENEX PHARMA
`The document wag recorded in the United States Patent and Trademark Office at
`
`
`
`
`Real , Frame_0588037233 _, of for which a copy thereof is attached.
`
`To: GALDERMALABORATORIESINC.
`4. FromCOLLAGENEY PHARMACEEUTICALS.ING.
`
`The document was recorded in the United States Patent and Trademark Office at
`
`SanefTSETINGLN
`Reel 037463
`Frame 0883_, or for which a copy thereof is attached.
`
`[7] Additional documents in the chain oftitle are listed on a supplemental sheet.
`LoS As required by 37 CFR 3.73(b)(1)(), the documentary evidence of the chain oftile from the original owner io the assignee was, or
`concurrently is being, submitted for recordation pursuant to 37 CFR 3.14.
`
`INOTE: A separate cony (.¢., a true copy of the original docurnent(s}) must be submitted to Assignment Division in
`accordance with 37 CFR Part 3, if the assignment is to be recorded in the records of the USPTO. See MPEP 302.08]
`| The undersigned (whosetitle is supplied below) is authorized to act on behaif of the assignes.
`
`
`7~ QaETRos
`
` ate,
`x
`<
`
`‘
`
`e SSS
`
`Signathre
`
`
`AttameyforApplicant
`
`oecnnnneabbnnee_unitTalapatra(Reg.
`
`Printed orath ad Name
`Title
`
`
`4
`i
`orevataa benefit Dy the public which |
`
`
`
`Yee)
`Baaantmnant ef om
`
`
`
`Rae EReyADUREAS SNS To:Daaesionfae Patents, PoRex (488, Stonandel wxee$458,
`
`
`
`ifvou need assistance in oompiating the form, call 1-800-F70-9799 and select aption2.
`
`4859-4319-7037.4
`
`